Molecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non‑neoplastic nature

Bergmann,Frank; Aulmann,Sebastian; Welsch,Thilo; Herpel,Esther; Werner,Jens; Schirmacher,Peter; Bläker,Hendrik

doi:10.3892/ol.2014.2163

Molecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non‑neoplastic nature

Authors:
- Frank Bergmann
- Sebastian Aulmann
- Thilo Welsch
- Esther Herpel
- Jens Werner
- Peter Schirmacher
- Hendrik Bläker
View Affiliations

Affiliations: Institute of Pathology, University of Heidelberg, Heidelberg D‑69120, Germany, Department of General Surgery, University of Heidelberg, Heidelberg D‑69120, Germany
Published online on: May 22, 2014 https://doi.org/10.3892/ol.2014.2163
Pages: 852-858

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The biology of pancreatic acinar cell cystadenomas has not been clearly defined. However, a non‑neoplastic process, caused by a cell differentiation failure leading to a cystic transformation, has been discussed, as well as a benign neoplastic lesion. Pancreatic acinar cell cystadenomas usually consist of thin‑walled unilocular or multilocular cysts, and mural nodules have been described in two cases of a recent series. In one of these nodules, chromosomal imbalances were detected, which provided preliminary evidence for a neoplastic process. The aim of the current study was to further characterize the lesions by molecular analyses. In four cases without mural nodules, the clonality was assessed by performing mutational analyses within the highly variable displacement‑loop region of the mitochondrial DNA. As a result, no closer correlation was identified between different foci within the tumors than between the tumors and adjacent normal pancreatic acinar tissue, indicating polyclonality of these lesions. Further molecular analyses revealed no mutations of the β‑catenin and K‑ras genes. In addition, no immunohistochemical evidence was identified for mutations of Smad4 or p53. In conclusion, the results of the current study demonstrated that pancreatic acinar cell cystadenomas are non‑neoplastic lesions, with the potential exception of those rare cases with mural nodules.

View Figures

View References

1	Campbell F and Azadeh B: Cystic neoplasms of the exocrine pancreas. Histopathology. 52:539–551. 2008.
2	Garcea G, Ong SL, Rajesh A, et al: Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology. 8:236–251. 2008.
3	Hruban RH, Bishop Pitman MB and Klimstra DS: Acinar cell cystadenoma. Tumors of the Pancreas AFIP Atlas of Tumor Pathology: Fourth Series. American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; Washington DC: pp. 191–193. 2007
4	Albores-Saavedra J: Acinar cystadenoma of the pancreas: a previously undescribed tumor. Ann Diagn Pathol. 6:113–115. 2002.
5	Chatelain D, Paye F, Mourra N, et al: Unilocular acinar cell cystadenoma of the pancreas an unusual acinar cell tumor. Am J Clin Pathol. 118:211–214. 2002.
6	Couvelard A, Terris B, Hammel P, et al: Acinar cystic transformation of the pancreas (or acinar cell cystadenoma), a rare and recently described entity. Ann Pathol. 22:397–400. 2002.(In French).
7	Gumus M, Ugras S, Algin O and Gundogdu H: Acinar cell cystadenoma (acinar cystic transformation) of the pancreas: the radiologic-pathologic features. Korean J Radiol. 12:129–134. 2011.
8	Khor TS, Badizadegan K, Ferrone C, et al: Acinar cystadenoma of the pancreas: a clinicopathologic study of 10 cases including multilocular lesions with mural nodules. Am J Surg Pathol. 36:1579–1591. 2012.
9	McEvoy MP, Rich B, Klimstra D, Vakiani E and La Quaglia MP: Acinar cell cystadenoma of the pancreas in a 9-year-old boy. J Pediatr Surg. 45:e7–e9. 2010.
10	Pesci A, Castelli P, Facci E, Romano L and Zamboni G: Primary retroperitoneal acinar cell cystadenoma. Hum Pathol. 43:446–450. 2012.
11	Zamboni G, Terris B, Scarpa A, et al: Acinar cell cystadenoma of the pancreas: a new entity? Am J Surg Pathol. 26:698–704. 2002.
12	Aulmann S, Penzel R, Longerich T, et al: Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat. 107:331–335. 2008.
13	Morandi L, Marucci G, Foschini MP, et al: Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch. 449:14–23. 2006.
14	Chenna R, Sugawara H, Koike T, et al: Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497–3500. 2003.
15	Clamp M, Cuff J, Searle SM and Barton GJ: The Jalview Java alignment editor. Bioinformatics. 20:426–427. 2004.
16	Bergmann F, Aulmann S, Wente MN, et al: Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40. J Clin Pathol. 59:580–584. 2006.
17	Kitaeva MN, Grogan L, Williams JP, et al: Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res. 57:4478–4481. 1997.
18	Bockman DE, Guo J, Büchler P, Müller MW, Bergmann F and Friess H: Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest. 83:853–859. 2003.
19	Abraham SC, Wu TT, Hruban RH, et al: Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol. 160:953–962. 2002.
20	Chadwick B, Willmore-Payne C, Tripp S, Layfield LJ, Hirschowitz S and Holden J: Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas. Appl Immunohistochem Mol Morphol. 17:31–39. 2009.
21	Löhr M, Klöppel G, Maisonneuve P, Lowenfels AB and Lüttges J: Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia. 7:17–23. 2005.
22	Sipos B, Frank S, Gress T, Hahn S and Klöppel G: Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology. 9:45–54. 2009.
23	Wada K: p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 9:76–85. 2002.
24	Abe K, Suda K, Arakawa A, et al: Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Pancreas. 34:85–91. 2007.
25	Lüttges J, Galehdari H, Bröcker V, et al: Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol. 158:1677–1683. 2001.
26	Sasaki S, Yamamoto H, Kaneto H, et al: Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep. 10:21–25. 2003.
27	Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60:2002–2006. 2000.
28	Biankin AV, Biankin SA, Kench JG, et al: Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. 50:861–868. 2002.
29	Hoorens A, Lemoine NR, McLellan E, et al: Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol. 143:685–698. 1993.
30	Moore PS, Orlandini S, Zamboni G, et al: Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer. 84:253–262. 2001.
31	Pellegata NS, Sessa F, Renault B, et al: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res. 54:1556–1560. 1994.
32	Rigaud G, Moore PS, Zamboni G, et al: Allelotype of pancreatic acinar cell carcinoma. Int J Cancer. 88:772–777. 2000.
33	Terhune PG, Heffess CS and Longnecker DS: Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog. 10:110–114. 1994.
34	Schmidt CM, Matos JM, Bentrem DJ, Talamonti MS, Lillemoe KD and Bilimoria KY: Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 12:2078–2086. 2008.
35	Wisnoski NC, Townsend CM Jr, Nealon WH, Freeman JL and Riall TS: 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma. Surgery. 144:141–148. 2008.
36	Raimondi S, Maisonneuve P and Lowenfels AB: Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 6:699–708. 2009.
37	Klöppel G: Pseudocysts and other non-neoplastic cysts of the pancreas. Semin Diagn Pathol. 17:7–15. 2000.